Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $453.90 | Total: $2,269.50 |
| 1 | 10 | $384.48 | Total: $3,844.80 |
| 1 | 25 | $325.74 | Total: $8,143.50 |
| 1 | 50 | $277.68 | Total: $13,884.00 |
| 1 | 100 | $240.30 | Total: $24,030.01 |
Overview
Fipamezole is a potent alpha2 adrenergic receptor antagonist that may be useful for studying autonomic dysfunction in Parkinson's disease.
Chemical Properties
| Molecular Formula | C14H15FN2 |
| Molecular Weight | 230.28 |
| CAS Numbers | 150586-58-6 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(C)C1(CC=2C(C1)=CC=C(F)C2)C3=CN=CN3 |
Storage and Handling
0C Short Term, -20C Long Term
References
Savola JM, et al. Fipamezole [JP-1730] is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease. Mov Disord. 2003 Aug;18[8] 872-83.